Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.
about
HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathwayDietary fructose and glucose differentially affect lipid and glucose homeostasisEffects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefitHDL particle number and size as predictors of cardiovascular diseaseComputational lipidology: predicting lipoprotein density profiles in human blood plasmaAn in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathwayNovel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients.The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphismHigh-density lipoprotein particle subclass heterogeneity and incident coronary heart disease.Comparison of Postprandial Responses to a High-Fat Meal in Hypertriglyceridemic Men and Women before and after Treatment with Fenofibrate in the Genetics and Lipid Lowering Drugs and Diet Network (GOLDN) Study.The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.Short communication: effects of omega-3 fatty acids on triglycerides and high-density lipoprotein subprofiles in HIV-infected persons with hypertriglyceridemiaEffects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women.Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux.Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status.Atherogenic dyslipidemia: cardiovascular risk and dietary interventionMarkers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without DiabetesNiacin: another look at an underutilized lipid-lowering medication.Relationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography.Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography.Tristetraprolin-dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3.Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy.HDL-3 is a superior predictor of carotid artery disease in a case-control cohort of 1725 participants.The association between dyslipidemia and anthropometric indicators in black and white adolescents residing in Tlokwe Municipality, North-West Province, South Africa: the PAHL study.Vasomotor symptoms and lipid profiles in women transitioning through menopauseEffects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels.HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.Ruminant-produced trans-fatty acids raise plasma HDL particle concentrations in intact and ovariectomized female Hartley guinea pigs.Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndromeHigh-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes.Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial.The I405V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosis.The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.Effect of fenofibrate therapy and ABCA1 polymorphisms on high-density lipoprotein subclasses in the Genetics of Lipid Lowering Drugs and Diet Network.Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trialHigh-Density Lipoproteins for Therapeutic Delivery Systems.The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight lossHuman serum preβ1-high density lipoprotein levels are independently and negatively associated with coronary artery diseases.Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
P2860
Q24323992-9B08DCBA-6228-4CEB-85DB-0BE7F2B56059Q24642206-9E674CAF-3FA7-4967-8FCA-13469367DD79Q24650533-1BD3B89E-7B30-454C-8D12-5DC51D00230BQ26779287-61CB49C4-E64B-4384-BF50-0F29C5893A33Q28472676-74CD9430-7AE1-4EB3-8765-D3EEBA144649Q28540807-6041EB7D-BFAF-4144-B6CF-F7865AB339A6Q30423610-BE8621E1-F3D9-4318-B3E4-91FB1158A4C6Q33730096-E4E95348-A6CD-4DA6-8DF4-8F0961196D8FQ33737098-55A2A8D3-3B6F-4966-AF5D-CC48CA05488CQ33795981-996D5FE8-3F7B-45D4-8CFC-CB0F5DDE3E29Q33837099-7D49862B-9F71-4E6B-9FA0-F499924118C0Q33988254-2C228801-09F2-43C7-A9A1-07AEE92228E4Q33993240-D0C5D615-9675-4B9C-BB54-B8E5F998A067Q34101172-920D2384-9933-4E30-A29C-D6CA3BD64EB4Q34163992-196CA378-145D-4A3F-98F3-28E14AC82025Q34180234-BBAA9E47-386D-4BE7-8040-408E4C9D5C32Q34203358-BD2DA814-D6F2-4702-936E-681D93F5DB0DQ34255686-A9EA7F95-C738-4C50-BB05-671F1247BCB8Q34508691-2B3570A2-C54F-4E3F-B04A-625BBA51F92AQ34560793-76E19887-DBA0-4843-BF72-ECAB749B4526Q34799841-2EAD4068-7376-4383-A5A4-33DA2D58F0F7Q34931247-557DDF81-5656-43AD-AA00-8BECC43D3850Q35021827-8C2C0BD5-AFEE-42C8-BBF7-E712CE762011Q35207181-7E8C3B8F-218A-4B13-9D05-15E3984026C9Q35932325-6604A4CB-1CD6-41F6-8885-37303CA4871DQ36045956-D2B54EBF-7DD5-423C-9794-7015F1398BC6Q36093194-E7DB8D92-9ED0-4FC5-A04C-D8ADC22431A2Q36160317-7B6F5E61-1A65-4B9E-8F4F-8E09CE74DD98Q36176111-59047109-6520-49E6-BA09-8F0004E2B5D9Q36335099-6BC171C9-52CD-4E63-BF90-1A96B06DD16FQ36372677-C2D63A91-851D-4036-82FB-16FAFA43706DQ36416117-F3B7C693-927D-4149-8049-DB18C7491359Q36455901-F3AED3C7-B1D8-4FF5-9DA1-83475C5DEE68Q36540608-312CA0F5-0FED-4937-B277-2AB08BFDD167Q36687632-91266FA1-B628-4A73-AF5F-39523A91233FQ36730543-21DAEAFF-8910-41B2-A84C-9318C99FD062Q36781321-1AF486B6-C8F7-47CB-9105-16476F28B7F4Q36807054-50815166-9610-4509-834B-10B1F757B0ABQ36907281-81730DCD-428E-4BDA-A46C-94A84A20CBE1Q36955395-9B907685-F721-4A1F-AF58-C8052CFDF20C
P2860
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Value of high-density lipoprot ...... ffairs HDL Intervention Trial.
@en
Value of high-density lipoprotein
@nl
type
label
Value of high-density lipoprot ...... ffairs HDL Intervention Trial.
@en
Value of high-density lipoprotein
@nl
prefLabel
Value of high-density lipoprot ...... ffairs HDL Intervention Trial.
@en
Value of high-density lipoprotein
@nl
P2093
P50
P921
P1476
Value of high-density lipoprot ...... ffairs HDL Intervention Trial.
@en
P2093
Bela F Asztalos
Dorothea Collins
Ernst J Schaefer
Katalin V Horvath
P304
P356
10.1161/01.ATV.0000183727.90611.4F
P407
P577
2005-08-25T00:00:00Z